Avantor Stock (NYSE:AVTR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$9.69

52W Range

$7.26 - $15.93

50D Avg

$8.63

200D Avg

$10.45

Market Cap

$6.88B

Avg Vol (3M)

$9.38M

Beta

0.96

Div Yield

-

AVTR Company Profile


Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

13,500

IPO Date

May 17, 2019

Website

AVTR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Proprietary Materials And Consumables$3.45B$3.62B$2.54B
Third Party Materials And Consumables$3.10B$3.17B$2.54B
Equipment And Instrumentation--$928.00M
Services And Specialty Procurement--$963.50M

Fiscal year ends in Dec 25 | Currency in USD

AVTR Financial Summary


Dec 25Dec 24Dec 23
Revenue-$6.78B$6.97B
Operating Income$-246.20M$1.08B$696.40M
Net Income$-530.20M$711.50M$321.10M
EBITDA$-246.20M$1.48B$1.10B
Basic EPS-$1.05$0.48
Diluted EPS-$1.04$0.47

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Apr 29, 26 | 12:00 AM
Q4 25Feb 11, 26 | 12:00 AM
Q3 25Oct 29, 25 | 8:00 AM

Peer Comparison


TickerCompany
ATRAptarGroup, Inc.
RGENRepligen Corporation
BIOBio-Rad Laboratories, Inc.
BAXBaxter International Inc.
MOHMolina Healthcare, Inc.
GRFSGrifols, S.A.
MASIMasimo Corporation
STVNStevanato Group S.p.A.
HSICHenry Schein, Inc.